bibliographicCitation |
Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD, Hosey L, Roa J, Patel N, Aldrovandi G, Murtaugh W, Cooper M, Gutzman H, Knowles K, Bowman R, Giganti M, Erhardt B, Adams S, . Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial. 2023 Aug 31;228(Supplement_2):S92–S100. doi: 10.1093/infdis/jiad209. |